Iron infusion to treat anemia in advanced stomach cancer patients

This trial is testing a medication called ferric carboxymaltose, given as a single intravenous infusion, to treat anemia (low red blood cell counts) in people with advanced stomach cancer who are starting chemotherapy. Stomach cancer often causes anemia because of internal bleeding and poor nutrition, and chemotherapy can make it worse. The study will compare people who receive this iron infusion to those who receive standard care with oral iron pills, to see if the infusion works better and is safe.

Many people with advanced stomach cancer develop anemia, which makes them feel weak and tired and can interfere with their ability to tolerate chemotherapy. Oral iron pills don't work well in stomach cancer patients because of digestive problems and ongoing bleeding, so researchers want to see if giving iron directly into the bloodstream is a better option.